APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.
Tran KM, Kwang NE, Butler CA, Gomez-Arboledas A, Kawauchi S, Mar C, Chao D, Barahona RA, Da Cunha C, Tsourmas KI, Shi Z, Wang S, Collins S, Walker A, Shi KX, Alcantara JA, Neumann J, Duong DM, Seyfried NT, Tenner AJ, LaFerla FM, Hohsfield LA, Swarup V, MacGregor GR, Green KN.
Tran KM, et al. Among authors: shi kx.
Mol Neurodegener. 2025 Jan 22;20(1):9. doi: 10.1186/s13024-024-00793-x.
Mol Neurodegener. 2025.
PMID: 39844286